Form 13-F position report

CORBUS PHARMACEUTICALS HLDG

Reported by D E Shaw & Co Inc

CRBP CUSIP 21833P103 Manager CIK 0001009207

Reported 0 shares, down 982,916 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 15 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 505000
2022-03-31 522000
2022-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for CORBUS PHARMACEUTICALS HLDG held by D E Shaw & Co Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2022 Reduced 0 -982,916 (-100.0%) 0 $0 2022-08-15
Q1 2022 Added 982,916 +163,410 (19.9%) < 0.01% $522,000 2022-05-16
Q4 2021 Added 819,506 +140,790 (20.7%) < 0.01% $505,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

79 managers reported CORBUS PHARMACEUTICALS HLDG for Q2 2022.

Managers reporting CORBUS PHARMACEUTICALS HLDG in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ETF MANAGERS GROUP LLC Reduced 7,062,485 -4,260,515 0.05% $1,787,000 19 qtrs
Knoll Capital Management LLC Unchanged 5,045,870 0 0.73% $1,273,000 29 qtrs
VANGUARD GROUP INC Unchanged 4,292,163 0 < 0.01% $1,082,000 29 qtrs
Mirae Asset Global Investments Co Ltd Added 4,029,171 +274,217 < 0.01% $1,016,000 13 qtrs
BlackRock Inc Reduced 2,367,100 -189,473 < 0.01% $596,000 22 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 1,626,860 +469,669 < 0.01% $410,000 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 988,419 -78,362 < 0.01% $249,000 28 qtrs
PINNACLE ASSOCIATES LTD Reduced 910,006 -4,881 < 0.01% $230,000 10 qtrs
Ikarian Capital LLC Reduced 862,527 -135,100 0.04% $217,000 7 qtrs
IQ EQ FUND MANAGEMENT IRELAND Ltd Added 457,209 +21,924 0.02% $115,000 10 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.